D-0417-2025 Class II Ongoing
FDA drug recall D-0417-2025 was initiated by L'Oreal USA on Mar 5, 2025 and is designated Class II. Reason for recall: Chemical Contamination: This recall has been initiated due to detected trace levels of benzene. The recall status is ongoing. Affected quantity: 2,226,801 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- May 21, 2025
- Initiation Date
- Mar 5, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,226,801 bottles
Product description
La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, 40 mL (135 FL. OZ.) Tube per carton, La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, Laboratoire Dermatologique, CAI 86270, La Roche-Posay, France, UPC 883140500759.
Reason for recall
Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.
Distribution pattern
Nationwide in the USA
Code information
Lot #: MYX46W, Exp 04/30/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0417-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026